Subordinate Effect of -21M HLA-B Dimorphism on NK Cell Repertoire Diversity and Function in HIV-1 Infected Individuals of African Origin.
Adult
Africa
/ epidemiology
Alleles
Cells, Cultured
Cohort Studies
Coinfection
/ immunology
Cross-Sectional Studies
Cytomegalovirus
/ immunology
Cytomegalovirus Infections
/ epidemiology
Female
HIV Infections
/ epidemiology
HIV-1
HLA-B Antigens
/ genetics
Humans
Killer Cells, Natural
/ immunology
Middle Aged
Polymorphism, Genetic
Young Adult
HCMV
HIV-1
HLA-B
HLA-C
Natural Killer cells
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2020
2020
Historique:
received:
16
10
2019
accepted:
21
01
2020
entrez:
6
3
2020
pubmed:
7
3
2020
medline:
9
3
2021
Statut:
epublish
Résumé
Natural Killer (NK) cells play an important role in antiviral defense and their potent effector function identifies them as key candidates for immunotherapeutic interventions in chronic viral infections. Their remarkable functional agility is achieved by virtue of a wide array of germline-encoded inhibitory and activating receptors ensuring a self-tolerant and tunable repertoire. NK cell diversity is generated by a combination of factors including genetic determinants and infections/environmental factors, which together shape the NK cell pool and functional potential. Recently a genetic polymorphism at position -21 of HLA-B, which influences the supply of HLA-E binding peptides and availability of HLA-E for recognition by the inhibitory NK cell receptor NKG2A, was shown to have a marked influence on NK cell functionality in healthy human cytomegalovirus (HCMV) seronegative Caucasian individuals. In this study, -21 methionine (M)-expressing alleles supplying HLA-E binding peptides were largely poor ligands for inhibitory killer immunoglobulin-like receptors (KIRs), and a bias to NKG2A-mediated education of functionally-potent NK cells was observed. Here, we investigated the effect of this polymorphism on the phenotype and functional capacity of peripheral blood NK cells in a cohort of 36 African individuals with human immunodeficiency virus type 1 (HIV-1)/HCMV co-infection. A similarly profound influence of dimorphism at position -21 of HLA-B on NK cells was not evident in these subjects. They predominantly expressed African specific HLA-B and -C alleles that contribute a distinct supply of NKG2A and KIR ligands, and these genetic differences were compounded by the marked effect of HIV-1/HCMV co-infection on NK cell differentiation. Together, these factors resulted in a lack of correlation of the HLA-B -21 polymorphism with surface abundance of HLA-E and loss of the NK cell functional advantage in subjects with -21M HLA-B alleles. Instead, our data suggest that during HIV/HCMV co-infection exposure of NK cells to an environment that displays altered HLA-E ligands drives adaptive NKG2C+ NK cell expansions influencing effector responses. Increased efforts to understand how NK cells are functionally calibrated to self-HLA during chronic viral infections will pave the way to developing targeted therapeutic interventions to overcome the current barriers to enhancing immune-based antiviral control.
Identifiants
pubmed: 32132995
doi: 10.3389/fimmu.2020.00156
pmc: PMC7041644
doi:
Substances chimiques
HLA-B Antigens
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
156Subventions
Organisme : Medical Research Council
ID : MR/K012037/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K012037
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI147778
Pays : United States
Organisme : Medical Research Council
ID : MR/M008614
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : UM1 AI144371
Pays : United States
Informations de copyright
Copyright © 2020 Cubero, Ogbe, Pedroza-Pacheco, Cohen, Haynes, Borrow and Peppa.
Références
Nature. 1998 Feb 19;391(6669):795-9
pubmed: 9486650
Immunity. 2015 Oct 20;43(4):634-45
pubmed: 26488815
Cell Host Microbe. 2016 May 11;19(5):686-95
pubmed: 27173934
Curr Opin Virol. 2016 Feb;16:15-23
pubmed: 26590692
Front Immunol. 2018 Mar 16;9:474
pubmed: 29616021
Immunity. 1999 Jun;10(6):661-71
pubmed: 10403641
Eur J Immunol. 1999 Feb;29(2):537-47
pubmed: 10064069
J Infect Dis. 2006 Jul 1;194(1):38-41
pubmed: 16741880
J Infect Dis. 2007 Jan 1;195(1):158-9; author reply 159-60
pubmed: 17152020
Sci Immunol. 2016 Sep;1(3):
pubmed: 27868107
Science. 2000 Feb 11;287(5455):1031
pubmed: 10669413
Curr HIV/AIDS Rep. 2016 Apr;13(2):85-94
pubmed: 27002078
Eur J Immunol. 2012 Feb;42(2):447-57
pubmed: 22105371
Science. 2018 Jan 5;359(6371):86-90
pubmed: 29302013
Hum Immunol. 1997 Jan;52(1):33-40
pubmed: 9021407
J Immunol. 2019 Oct 15;203(8):2301-2309
pubmed: 31519864
J Immunol Res. 2014;2014:298569
pubmed: 24839609
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2886-91
pubmed: 15699323
PLoS Pathog. 2018 Sep 4;14(9):e1007257
pubmed: 30180214
Clin Immunol. 2009 Nov;133(2):238-44
pubmed: 19762282
Blood. 2013 Apr 4;121(14):2678-88
pubmed: 23325834
Nat Immunol. 2018 May;19(5):453-463
pubmed: 29632329
EMBO J. 1999 Aug 2;18(15):4250-60
pubmed: 10428963
J Virol. 2011 Apr;85(7):3367-74
pubmed: 21248048
J Infect Dis. 2012 Jun 15;205(12):1797-805
pubmed: 22492862
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5140-5
pubmed: 11309482
Nat Commun. 2018 Aug 7;9(1):3137
pubmed: 30087334
J Immunol. 2013 Sep 1;191(5):2708-16
pubmed: 23918974
J Infect Dis. 2015 Sep 15;212(6):845-52
pubmed: 25748324
Curr Opin Immunol. 2018 Feb;50:102-111
pubmed: 29413815
J Virol. 2009 Sep;83(17):8705-12
pubmed: 19553339
Cell Rep. 2018 Aug 21;24(8):1967-1976.e4
pubmed: 30134159
Immunity. 2015 Mar 17;42(3):443-56
pubmed: 25786176
Blood. 2006 May 1;107(9):3624-31
pubmed: 16384928
J Immunol. 1998 May 15;160(10):4951-60
pubmed: 9590243
Clin Exp Immunol. 2013 Dec;174(3):414-23
pubmed: 23952339
Blood. 2010 Nov 11;116(19):3853-64
pubmed: 20696944
J Infect Dis. 2009 Sep 1;200(5):820-6
pubmed: 19619059
Nature. 2011 Apr 28;472(7344):495-8
pubmed: 21499264